NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $369 | -18.0% | 116,800 | +0.3% | 0.00% | 0.0% |
| Q2 2023 | $450 | +47.5% | 116,400 | +5.6% | 0.00% | – |
| Q1 2023 | $305 | +70.4% | 110,200 | +10.8% | 0.00% | – |
| Q4 2022 | $179 | -99.9% | 99,500 | +11.7% | 0.00% | – |
| Q3 2022 | $189,000 | +10.5% | 89,100 | +40.1% | 0.00% | – |
| Q2 2022 | $171,000 | +256.2% | 63,600 | +478.2% | 0.00% | – |
| Q1 2022 | $48,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $19,026 | 6.52% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $4,284,679 | 4.48% |
| ArchPoint Investors | 1,449,551 | $4,580,581 | 1.75% |
| Tikvah Management LLC | 1,313,895 | $4,151,908 | 1.49% |
| Perceptive Advisors | 9,111,151 | $28,791,237 | 0.96% |
| Cercano Management LLC | 7,172,985 | $22,666,633 | 0.81% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $6,320,000 | 0.71% |
| HILLMAN CO | 200,000 | $632,000 | 0.38% |
| Comprehensive Financial Management LLC | 2,207,619 | $6,976,076 | 0.25% |
| Clarius Group, LLC | 597,769 | $1,888,950 | 0.18% |